Showing results (11-20 of 31) with videos related to
Sort By:
Pageof 4
Melanoma Research|September 1, 1992
Expression of cytokine genes, including IL-6, in human malignant melanoma cell linesM P Colombo, C Maccalli, S Mattei, et al.Blood|January 15, 1997
Differential susceptibility to HIV-GP120-sensitized apoptosis in CD4+ T-cell clones with different T-helper phenotypes: role of CD95/CD95L interactionsP Accornero, M Radrizzani, D Delia, et al.Cancer Research|May 1, 1988
Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytesC Gambacorti-Passerini, L Rivoltini, R Supino, et al.Cellular Immunology|March 1, 1995
IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3/TCR activation or by IL-2 deprivationM Radrizzani, P Accornero, A Amidei, et al.FEBS Letters|November 4, 1998
HIV/gp120 and PMA/ionomycin induced apoptosis but not activation induced cell death require PKC for Fas-L upregulationP Accornero, M Radrizzani, A Carè, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cellsM Radrizzani, M Quaia, B Benedetti, et al.Journal of Immunological Methods|May 4, 2001
Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the proteinM Bianchini, M Radrizzani, M G Brocardo, et al.International Journal of Cancer|December 2, 1991
Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactionsM Radrizzani, B Benedetti, C Castelli, et al.Tumori|October 31, 1988
A new procedure for large scale production and freezing of lymphokine activated killer (LAK) cells to be used in adoptive immunotherapy of cancerC Gambacorti-Passerini, M Radrizzani, L Rivoltini, et al.Medicina|February 7, 2001
Oligobodies: bench made synthetic antibodiesM Radrizzani, M Broccardo, C González Solveyra, et al.Pageof 4